Published February 2009 | Version v1
Journal article

Renal toxicity in children undergoing total body irradiation for bone marrow transplant

  • 1. Department of Radiation Oncology, Emory University School of Medicine, Atlanta, CA (United States)
  • 2. Children's Healthcare of Atlanta, Atlanta, CA (United States)
  • 3. Department of Radiation Oncology, University of Chicago, Chicago, IL (United States)
  • 4. Keyserling Cancer Center, Port Royal, SC (United States)
  • 5. Naval Medical Center, San Diego, CA (United States)
  • 6. Department of Radiation Oncology, Baylor College of Medicine, Houston, TX (United States)

Description

Purpose: Contribution of total body irradiation (TBI) to renal toxicity in children undergoing the bone marrow transplant (BMT) remains controversial. We report our institutional retrospective study that evaluates the frequency of acute and chronic renal dysfunction in children after using total body irradiation (TBI) conditioning regimens. Materials and methods: Between 1995 and 2003, 60 children with hematological malignancies underwent TBI as part of a conditioning regimen before allogeneic BMT. Patients received 4-14 Gy at 1.75-2 Gy/fraction in six-eight fractions. Lung shielding was used in all patients to limit lung dose to less than 10 Gy; renal shielding was not utilized. All patients had baseline renal function assessment and renal dysfunction post-BM was mainly evaluated on the basis of persistent serum creatinine elevation at acute (0-90 days) and chronic (>90 days) intervals after completion of BMT. Results: Acute renal dysfunction (ARD) was documented in 27 patients (45%); the majority had concurrent diagnosis of veno-occlusive disease (VOD) or graft-versus-host disease (GVHD) and other potential causes (sepsis, antibiotic). The risk for delayed renal dysfunction (DRD) at 1 year approached 25% for surviving patients. The ARD was strongly linked with the risk of the DRD. There was no statistically significant relationship between ARD, DRD and underlying diagnosis, GVHD, VOD or TBI doses with both univariate and multivariate analyses. The younger age (<5 years) had significantly increased risk for the development of ARD (p = 0.011). Conclusion: Our analysis validates high incidence of renal dysfunction in the pediatric BMT population. In contrast to other reports we did not find total body irradiation dose to be a risk factor for renal dysfunction. Future prospective studies are needed to assess risk factors and interventions for this serious toxicity in children following allogeneic BM

Availability note (English)

Available from http://dx.doi.org/10.1016/j.radonc.2008.09.017

Additional details

Identifiers

DOI
10.1016/j.radonc.2008.09.017;
PII
S0167-8140(08)00516-1;

Publishing Information

Journal Title
Radiotherapy and Oncology
Journal Volume
90
Journal Issue
2
Journal Page Range
p. 242-246
ISSN
0167-8140
CODEN
RAONDT

Optional Information

Copyright
Copyright (c) 2008 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.